Sign in
BIORQ Stock Price, Chart, Stats & News
Biora Therapeutics, Inc.
Save
Biora Therapeutics, Inc. (BIORQ) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
BIORQ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -1678575.00% |
Pretax margin | -3110600.00% |
Net margin | -3102875.00% |
Effective tax rate | 0.07% |
ROA | -397.61% |
ROE | 121.86% |
D/E | -0.47x |
Interest coverage ratio | -6.84x |
BIORQ valuation
P/E | – |
P/S | 0.00x |
P/B | -0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | 0.00x |
EV multiple | 0.28x |
About
Biora Therapeutics, Inc. operates as a biotechnology company, primarily focused on developing innovative oral biotherapeutics. The company's core efforts include: 1. Targeted Therapeutics Program: This initiative employs an advanced, ingestible smart capsule engineered for the precise administration of medications directly within the gastrointestinal (GI) tract.
Similar securities
Based on sector and market capitalization
Report issue